LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 3 of 15: Cell count and relative growth within biological replicate 3. - Dataset - HMS LINCS Database

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 3 of 15: Cell count and relative growth within biological replicate 3. - Dataset (ID:20239)

Download: Excel (XLSX), Comma-separated (CSV)

<<<<

Select the entities to show:

Small molecules	Cells

|<
<<
Previous
Page 28 of 497
Next
>>
>
676 to 700 of 12420 records
per page:

Cell	Small Molecule	Small Mol Concentration	Small Mol Conc Unit	LJP Library Plate	Replicate	Assay Well	Timepoint	Timepoint Unit	Total Cell Count Before Treatment	Total Cell Count After Treatment	Total Control Cell Count	Relative Cell Count	Relative Growth Rate After Treatment
BT-20	WZ3105	0.12	uM	LJP5	1	D23	72	hr	1097	1283	3769	0.3404	0.0695
BT-20	WZ3105	0.12	uM	LJP5	2	D23	72	hr	1097	1237	3769	0.3282	0.0523
BT-20	WZ3105	0.12	uM	LJP5	3	D23	72	hr	1097	1359	3769	0.3605	0.0979
BT-20	XMD11-50	0.12	uM	LJP6	1	P11	72	hr	1097	2583	3769	0.6852	0.5560
BT-20	XMD11-50	0.12	uM	LJP6	2	P11	72	hr	1097	2664	3769	0.7067	0.5863
BT-20	XMD11-50	0.12	uM	LJP6	3	P11	72	hr	1097	2841	3769	0.7537	0.6525
BT-20	Y39983	0.12	uM	LJP6	1	P05	72	hr	1097	3429	3769	0.9097	0.8726
BT-20	Y39983	0.12	uM	LJP6	2	P05	72	hr	1097	3401	3769	0.9022	0.8621
BT-20	Y39983	0.12	uM	LJP6	3	P05	72	hr	1097	3504	3769	0.9296	0.9006
BT-20	YM 201636	0.12	uM	LJP5	1	N11	72	hr	1097	3634	3769	0.9640	0.9493
BT-20	YM 201636	0.12	uM	LJP5	2	N11	72	hr	1097	4010	3769	1.0638	1.0900
BT-20	YM 201636	0.12	uM	LJP5	3	N11	72	hr	1097	3824	3769	1.0144	1.0204
BT-20	ZSTK474	0.12	uM	LJP6	1	M17	72	hr	1097	2907	3769	0.7712	0.6772
BT-20	ZSTK474	0.12	uM	LJP6	2	M17	72	hr	1097	2612	3769	0.6929	0.5668
BT-20	ZSTK474	0.12	uM	LJP6	3	M17	72	hr	1097	2581	3769	0.6847	0.5552
BT-20	Afatinib	0.37	uM	LJP6	1	G22	72	hr	1097	3214	3769	0.8526	0.7921
BT-20	Afatinib	0.37	uM	LJP6	2	G22	72	hr	1097	3245	3769	0.8609	0.8037
BT-20	Afatinib	0.37	uM	LJP6	3	G22	72	hr	1097	2784	3769	0.7386	0.6312
BT-20	Sigma A6730	0.37	uM	LJP5	1	B22	72	hr	1097	3161	3769	0.8386	0.7723
BT-20	Sigma A6730	0.37	uM	LJP5	2	B22	72	hr	1097	3646	3769	0.9672	0.9538
BT-20	Sigma A6730	0.37	uM	LJP5	3	B22	72	hr	1097	3729	3769	0.9893	0.9848
BT-20	Alvocidib	0.37	uM	LJP6	1	A16	72	hr	1097	617	3769	0.1637	-0.1797
BT-20	Alvocidib	0.37	uM	LJP6	2	A16	72	hr	1097	619	3769	0.1642	-0.1790
BT-20	Alvocidib	0.37	uM	LJP6	3	A16	72	hr	1097	597	3769	0.1584	-0.1872
BT-20	AT-7519	0.37	uM	LJP6	1	K04	72	hr	1097	710	3769	0.1884	-0.1449

|<
<<
Previous
Page 28 of 497
Next
>>
>
676 to 700 of 12420 records
per page:

HMS LINCS Project

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 3 of 15: Cell count and relative growth within biological replicate 3. - Dataset (ID:20239)